Importantly, given the complete absence of CLEC12A on normal CD34+CD38− cells, evaluating CLEC12A expression on CD34+CD38− cells might be a useful diagnostic tool in MDS, representing a “different from normal”‐approach. Here, CLEC12A is linked to myelodysplastic syndrome.